Table 3.
β | HR | se(β) | Z | P | |
---|---|---|---|---|---|
Age | 0.014 | 1.010 | 0.001 | 15.150 | <0.0001 |
Sex | |||||
Female | Ref | ||||
Male | 0.082 | 1.090 | 0.023 | 3.540 | 0.0004 |
Tumor site | |||||
Colon, unknown | Ref | ||||
Left colon | 31.34 | 5.05×105 | 1.79×102 | 0.073 | 0.9414 |
Overlapping lesion | 34.22 | 6.74×105 | 1.79×102 | 0.075 | 0.9401 |
Right colon | 33.83 | 6.48×105 | 1.79×102 | 0.075 | 0.9403 |
Transverse colon | 33.99 | 6.58×105 | 1.79×102 | 0.075 | 0.9402 |
Histological type | |||||
Adenocarcinoma | Ref | ||||
Not adenocarcinoma | 0.160 | 1.170 | 0.042 | 3.810 | 0.0001 |
Tumor differentiation grade | |||||
II | Ref | ||||
IV | 0.544 | 1.720 | 0.052 | 10.510 | <0.0001 |
I | -0.408 | 0.665 | 0.056 | -7.230 | <0.0001 |
III | 0.385 | 1.470 | 0.027 | 14.080 | <0.0001 |
T category | |||||
T0 | Ref | ||||
T1 | -0.399 | 0.671 | 1.000 | -0.397 | 0.6916 |
T2 | -0.925 | 0.397 | 1.010 | -0.917 | 0.3589 |
T3 | -0.556 | 0.573 | 1.010 | -0.554 | 0.5800 |
T4 | -0.281 | 0.755 | 1.010 | -0.280 | 0.7794 |
TX | -0.383 | 0.682 | 1.000 | -0.382 | 0.7026 |
N category | |||||
N0 | Ref | ||||
N1 | 0.151 | 1.160 | 0.033 | 4.618 | <0.0001 |
N2 | 0.455 | 1.580 | 0.037 | 12.460 | <0.0001 |
NX | 0.166 | 1.180 | 0.051 | 3.281 | 0.0010 |
Bone metastasis | |||||
No | Ref | ||||
Yes | 0.362 | 1.440 | 0.056 | 6.426 | <0.0001 |
Brain metastasis | |||||
No | Ref | ||||
Yes | 0.432 | 1.540 | 0.125 | 3.460 | <0.0001 |
Lung metastasis | |||||
No | Ref | ||||
Yes | 0.278 | 1.320 | 0.030 | 9.285 | <0.0001 |
Tumor deposit | |||||
No | Ref | ||||
Unknown | 0.197 | 1.220 | 0.032 | 6.250 | <0.0001 |
Yes | 0.112 | 1.120 | 0.038 | 2.943 | 0.0032 |
Tumor size | |||||
0-1cm | Ref | ||||
1-5cm | 0.296 | 1.340 | 0.231 | 1.281 | 0.2003 |
unknown | -0.082 | 0.921 | 0.037 | -2.255 | 0.0241 |
Surgery | |||||
No | Ref | ||||
Yes | -0.806 | 0.447 | 0.049 | -16.462 | <0.0001 |
Chemotherapy | |||||
No | Ref | ||||
Yes | -1.086 | 0.338 | 0.026 | -42.532 | <0.0001 |
OS, overall survival; HR, hazard ratio; CI, confidence interval.